Plasma galanin, vasopressin, and oxytocin in patients with addison's disease

Hormone and Metabolic Research

Volumn 39, Issue 8, 2007, Pages 589-595

  Grenback E ^a,b   Hulting, A L ^a   Bucht, E ^a   Petersson, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACTH; CRH; Hypothalamus; Nelson; Pituitary

Indexed keywords

CORTICOTROPIN; CORTISONE ACETATE; FLUDROCORTISONE; GALANIN; HYDROCORTISONE; NEUROPEPTIDE; OXYTOCIN; PREDNISOLONE; THYROXINE; VASOPRESSIN;

ADDISON DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG SUBSTITUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHYROIDISM; LABORATORY TEST; MALE; NELSON SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADDISON DISEASE; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GALANIN; HUMANS; MALE; MIDDLE AGED; OXYTOCIN; VASOPRESSINS;

EID: 34548327194     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985130     Document Type: Article

References (58)

1. Veldhuis JD, Iranmanesh A, Naftolowitz D, Tatham N, Cassidy F, Carroll BJ. Corticotropin secretory dynamics in humans under low glucocorticoid feedback. J Clin Endocrinol Metab 2001; 86: 5554-5563
2. Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin- releasing factor concentrations in peripheral plasma. J Clin Endocrinol Metab 1993; 76: 192-196
3. Fadeev VV, Gitel EP, Mel'nichenko GA. The diurnal rhythm of adrenocorticotrophic hormone secretion in the assessment of the adequacy of replacement therapy in primary chronic adrenal failure. Neurosci Behav Physiol 2001; 31: 237-242
4. Tatemoto K, Rökeus Å, Jörnvall H, MacDonald T, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-128
5. Schmidt WF, Kratzin H, Eckhart K, Drevs D, Mundkowski G, Clemens A, Katsoulis S, Schäfer H, Gallwitz B, Creutzfeldt W. Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated peptide. Proc Natl Acad Sci USA 1991; 88: 11435-11439
6. Evans HF, Shine J. Human galanin: molecular cloning reveals a unique structure. Endocrinology 1991; 129: 1682-1684
7. MacKnight GL, Karlsen AE, Kowalyk S, Mathewes SL, Sheppard PO, O'Hara PJ, Taborski GJ. Sequence of human galanin and its inhibition of glucose-stimulated insulin from RIN cells. Diabetes 1992; 41: 82-87
8. Bersani M, Johnsen AH, Højrup P, Dunning BE, Andreasen JJ, Holst JJ. Human galanin: primary structure and identification of two molecular forms. FEBS Lett 1991; 283: 189-194
9. Rökaeus Å, Melander T, Hökfelt T, Lundberg JM, Tatemoto M, Carlquist M, Mutt V. A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 1984; 47: 161-166
10. Skofitsch G, Jacobowitz DM. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985; 6: 509-546
11. Ceccatelli S, Eriksson M, Hökfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin-, and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 1989; 49: 309-323
12. Meister B, Villar MJ, Ceccatelli S, Hökfelt T. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations. Neuroscience 1990; 37: 603-633
13. Landry M, Roche D, Angelova E, Calas A. Expression of galanin in hypothalamic magnocellular neurones of lactating rats: co-existence with vasopressin and oxytocin. J Endocrinol 1997; 155: 467-481
14. Ceccatelli S, Cintra A, Hökfelt T, Fuxe K, Wikstrom AC, Gustafsson JA. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus. Exp Brain Res 1989; 78: 33-42
15. Sivukhina EV, Jirikowski GF, Bernstein HG, Lewis JG, Herbert Z. Expression of corticosteroid-binding protein in the human hypothalamus, co-localization with oxytocin and vasopressin. Horm Metab Res 2006; 38: 253-259
16. Kaplan LM, Hooi SC, Abraczinskas DR, Strauss RM, Davidson MB, Hsu DW, Koenig JI. Neuroendocrine regulation of galanin gene expression, in Hökfelt T, Bartfai T, Jacobowitz D, Ottoson D (ed.) Galanin, a new multifunctional peptide in the neuro-endocrine system. London, Macmillan, 1991: 43-65
17. Kaplan LM, Gabriel SM, Koenig JL, Sunday ME, Spindel ER, Martin JB, Chin WW. Galanin is an estrogen-inducible secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA 1988; 85: 7408-7412
18. Vrontakis ME, Sano T, Kovacs K, Friesen HG. Presence of galanin-like immunoreactivity in non-tumorous corticotrophs and corticotroph adenomas of the human pituitary. J Clin Endocrinol Metab 1990; 70: 747-751
19. Bennet WM, Hill SF, Ghatei MA, Bloom SR. Galanin in the normal pituitary and brain and in pituitary adenomas. J Endocrinol 1991; 130: 463-467
20. Hsu DW, Hooi SC, Hedley-Whyte T, Strauss RM, Kaplan LM. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Am J Pathol 1991; 138: 897-909
21. Invitti C, Pecori Giraldi F, Dubini A, Moroni P, Losa M, Picoletti R, Cavagnini F. Galanin is released by adrenocorticotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 1999; 84: 1351-1356
22. Leung B, Iismaa TP, Leung K-C, Hort YJ, Turner J, Sheehy JP, Ho KK. Galanin in human pituitary adenomas: frequency and clinical significance. Clin Endocrinol 2002; 56: 397-403
23. Grenbäck E, Bjellerup P, Wallerman E, Lundblad L, Änggård A, Ericson K, Äman K, Landry M, Schmidt WE, Hökfelt T, Hulting A-L. Galanin in pituitary adenomas. Regul Pept 2004; 117: 127-139
24. Jacobson L. Hypothalamic-pituitary-adrenocortical axis regulation. Endocrinol Metab Clin North Am 2005; 34: 271-292
25. Engelmann M, Landgraf R, Wotjak CT. The hypothalamic- neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004; 25: 132-149
26. Legros JJ. Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones. Psychoneuroendocrinology 2001; 26: 649-655
27. Ahmed ABJ, George BC, Gonzalez-Auvert C, Dingman JF. Increased plasma arginine vasopressin in clinical adrenocortical deficiency and its inhibition by glucosteroids. J Clin Invest 1967; 46: 111-123
28. Salmonez-Granier F, Leclerc-Coornaert L, Lefebre J, Racadot A, Linquette M. Study of antidiuretic hormones (arginine vasopressin) in 24 cases of primary adrenal insufficiency. Ann Endocrinol (Paris) 1983; 44: 371-376
29. Laczi F, Janaky T, Ivanyi T, Julesz J, Laszlo FA. Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease. Acta Endocrinol (Copenh) 1987; 114: 389-395
30. Conte-Devolx B, Frances Y, Oliver C, Giraud P, Gillioz P, Millet Y. Effect of substitutive therapy on plasma arginine vasopressin levels during water load in Addison disease. Acta Endocrinol (Copenh) 1979; 225 (Suppl): 215
31. Grenbäck E, Hulting A-L, Bucht E. Heterogenous forms of immunoreactive galanin in human plasma; higher levels in men than in women. Horm Metab Res 2005; 37: 290-296
32. Schmidt WE, Siegel EG, Lamberts R, Gallwitz B, Creutzfeld W. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988; 123: 1395-1404
33. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clinical Endocrinology 1981; 14: 451-458
34. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229: 131-134
35. Frolkis VV, Kvitnitskaya-Ryzhova TY, Dubiley TA. Vasopressin, hypothalamo-neurohypophyseal system and aging. Arch Gerontol Geriatr 1999; 29: 193-214
36. Forsling ML, Montgomery H, Halpin D, Windle RJ, Treacher DF. Daily patterns of neurohypophysial hormones in man: effect of age. Exp Physiol 1998; 83: 409-418
37. Ceresini G, Morganti S, Rebecchi I, Solerte SB, Ghizzoni L, Ablondi F, Valenti G. Evaluation of the circadian profile of peripheral plasma galanin concentrations in normal subjects. Life Sciences 2002; 70: 2657-2664
38. Ceresini G, Marchini L, Fabbo A, Freddi M, Pasolini G, Reali N, Troglio G, Valenti G. Evaluation of circulating galanin levels after exercise-induced pituitary hormone secretion in man. Metabolism 1997; 46: 282-286
39. Sundkvist G, Bramnert M, Bergström B, Manhem P, Lilja B, Ahrén B. Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction. Diabetes Res Clin Pract 1992; 15: 219-226
40. Ceresini G, Freddi M, Paccotti P, Valenti G, Merchenthaler I. Effects of ovine corticotropin-releasing hormone injection and desmopressin coadministration on galanin and adrenocorticotropin plasma levels in normal women. J Clin Endocrinol Metab 1997; 82: 607-610
41. Hinghofer-Szalkay HG, Rössler A, Evans JM, Stenger MB, Moore FB, Knapp CF. Circulatory galanin levels increase several fold with intense orthostatic challenge in healthy humans. J Appl Physiol 2006; 100: 844-849
42. López FJ, Meade Jr EH, Negro-Vilar A. Development and characterization of a specific and sensitive radioimmunoassay for rat galanin: measurement in brain tissue, hypophyseal portal and peripheral serum. Brain Res Bull 1990; 24: 395-399
43. Bersani M, Thim L, Rasmussen TN, Holst JJ. Galanin and galanin extended at the N-terminus with seven and nine amino acids are produced in and secreted from the porcine adrenal medulla in almost equal amounts. Endocrinology 1991; 129: 2693-2698
44. Harling H, Holst JJ. Circulating galanin: origin, metabolism, and pharmacokinetics in anesthetized pigs. Am J Physiol 1992; 262 (1pt1): E52-E57
45. Nussey SS, Page SR, Peterson DB, Byrne J, Crosby SR, White A, Ang VT, Jackson R, Jenkins JS. Corticotrophin releasing hormone (CRH1-41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors:evidence from petrosal sinus sampling in man. Clin Endocrinol (Oxf) 1991; 34: 51-56
46. Kalogeras KT, Nieman LK, Friedman TC, Doppman JL, Cutler Jr GB, Chrousos GP, Wilder RL, Gold PW, Yanovski JA. Inferior petrosal sinus sampling in healthy human subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. J Clin Invest 1996; 97: 2045-2050
47. Sawchenko PE. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. J Neurosci 1987; 7: 1093-1106
48. Kovacs KJ, Földes A, Sawchenko PE. Glucocorticoid negative feed-back selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 2000; 20: 3843-3852
49. Plotsky PM, Sawchenko PE. Hypophysial portal plasma levels, median eminence content and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 1987; 120: 1361-1369
50. Sawchenko PE, Swanson LW, Vale WW. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin immunoreactive neurons in the hypothalamus of the male rat. J Neurosci 1984; 4: 1118-1129
51. Fink G, Robinson IC, Tannahill LA. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood. J Physiol 1988; 401: 329-345
52. Bruhn TO, Sutton SW, Plotsky PM, Vale WW. Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat. Endocrinology 1986; 119: 1558-1563
53. Petersson M, Hulting A-L, Uvnäs-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 1999; 264: 41-44
54. Gibbs DM. Vasopressin and oxytocin: hypothalamic modulators and the stress response: a review. Psychoneuroendocrinology 1986; 11: 131-140
55. Nomura M, Saito J, Ueta Y, Muglia LJ, Pfaff DW, Ogawa S. Enhanced up-regulation of CRH gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient mice. J Neuroendocrinol 2003; 15: 1054-1061
56. Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 1984; 81: 1883-1887
57. Erkut ZA, Pool C, Swaab DF. Glucorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab 1998; 83: 2066-2073
58. Laguna-Abreu MTC, Koenigkam-Santos M, Colleta AMD, Elias PCL, Moreira AC, Antunes-Rodrigues J, Elias LL, Castro M. Time course of vasopressin and oxytocin secretion after stress in adrenalectomized rats. Horm Metab Res 2005; 37: 84-88